LHC Group announces third quarter 2022 financial results

Rhea-AI Summary

LHC Group, Inc. (NASDAQ: LHCG) reported a 2.0% increase in net service revenue for Q3 2022, totaling $576.9 million. The net income for common stockholders was $17.3 million, equating to $0.56 per diluted share, while adjusted net income reached $32.6 million, or $1.06 per adjusted diluted share. The adjusted EBITDA was $60.3 million. Due to the pending acquisition by UnitedHealth Group, no earnings call will follow this financial announcement.

Positive

• Net service revenue increased by 2.0% to $576.9 million.
• Adjusted net income attributable to shareholders was $32.6 million.

Negative

• Net income attributable to common stockholders decreased to $17.3 million.

LAFAYETTE, La., Nov. 2, 2022 /PRNewswire/ -- LHC Group, Inc. (NASDAQ: LHCG) announced its financial results for the quarter ended September 30, 2022.

Third Quarter 2022 Financial Results

• Net service revenue increased 2.0% to $576.9 million.
• Net income attributable to LHC Group's common stockholders was $17.3 million, or $0.56 per diluted share.
• Adjusted net income attributable to LHC Group's common stockholders was $32.6 million, or $1.06 adjusted earnings per diluted share.
• Adjusted EBITDA was $60.3 million.

A reconciliation of all non-GAAP financial results in this release appears on pages 8-9.

In light of the pending acquisition of the Company by UnitedHealth Group Incorporated ("UNH"), LHC Group will not conduct a quarterly earnings call to discuss the third quarter results.

About LHC Group, Inc.

LHC Group, Inc. is a national provider of in-home healthcare services and innovations for communities around the nation, offering quality, value-based healthcare to patients primarily within the comfort and privacy of their home or place of residence. The company's 29,000 employees deliver home health, hospice, home- and community-based services, and facility-based care in 37 states and the District of Columbia – reaching 68 percent of the U.S. population aged 65 and older. Through Imperium Health, the company's ACO management and enablement company, LHC Group helps partners improve both savings and patient outcomes with a value-based approach. As the preferred joint venture partner for more than 400 leading U.S. hospitals and health systems, LHC Group works in cooperation with providers to customize each partnership and reach more patients and families with an effective and efficient model of care.

Forward-looking Statements

This press release contains "forward-looking statements" (as defined in the Securities Litigation Reform Act of 1995) regarding, among other things, future events or the future financial performance of the Company, or the timing or anticipated benefits of pending acquisition of the Company by UnitedHealth Group Incorporated. Words such as "anticipate," "expect," "project," "intend," "believe," "will," "estimates," "may," "could," "should" and words and terms of similar substance used in connection with any discussion of future plans, actions or events identify forward-looking statements. Forward-looking statements are based on information currently available to the Company and involve estimates, expectations and projections. Investors are cautioned that all such forward-looking statements are subject to risks and uncertainties, and important factors could cause actual events or results to differ materially from those indicated by such forward-looking statements. These risks, uncertainties and other factors include, but are not limited to, those discussed and described in our most recent Annual Report on Form 10-K, including those risks described in Part I, Item 1A. Risk Factors thereof, and in other reports filed subsequently by us with the Securities and Exchange Commission and, with respect to the pending acquisition of the Company by UnitedHealth Group Incorporated, include, but are not limited to, those discussed in the proxy statement filed by the Company with the SEC on May 17, 2022. All forward-looking statements included in this document are based on information available to us on the date hereof, and the Company assumes no obligation to update any such forward-looking statements to reflect future events or circumstances, except as required by law.

 

LHC GROUP, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in thousands, except share data) (Unaudited)
	September 30, 2022		December 31, 2021
ASSETS
Current assets:
Cash	$         10,522		$          9,809
Receivables:
Patient accounts receivable	331,524		348,820
Other receivables	30,217		13,780
Total receivables	361,741		362,600
Prepaid income taxes	19,303		7,531
Prepaid expenses	23,128		28,401
Other current assets	25,687		24,801
Total current assets	440,381		433,142
Property, building and equipment, net of accumulated depreciation of $110,600 and $98,394, respectively	153,806		153,959
Goodwill	1,750,420		1,748,426
Intangible assets, net of accumulated amortization of $22,865 and $19,152, respectively	395,309		400,002
Operating lease right of use asset	108,975		113,399
Other assets	65,263		46,693
Total assets	$    2,914,154		$   2,895,621
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable and other accrued liabilities	$       108,748		$        98,118
Salaries, wages, and benefits payable	84,412		100,532
Self-insurance reserves	38,734		33,784
Contract liabilities - deferred revenue	4,840		106,489
Current operating lease payable	36,998		37,630
Amounts due to governmental entities	2,499		5,447
Current liabilities - deferred employer payroll tax	26,790		26,790
Total current liabilities	303,021		408,790
Deferred income taxes	87,661		70,026
Income taxes payable	7,988		7,320
Revolving credit facility	738,000		661,197
Long-term operating lease liabilities	74,992		78,688
Total liabilities	1,211,662		1,226,021
Noncontrolling interest — redeemable	16,978		17,501
Commitments and contingencies
Stockholders' equity:
LHC Group, Inc. stockholders' equity:
Preferred stock – $0.01 par value; 5,000,000 shares authorized; none issued or outstanding	—		—
Common stock — $0.01 par value; 60,000,000 shares authorized; 36,733,790 and 36,549,524 shares issued, and 30,587,735 and 30,634,414 shares outstanding, respectively	367		365
Treasury stock — 6,146,055 and 5,915,110 shares at cost, respectively	(195,447)		(164,790)
Additional paid-in capital	997,115		979,642
Retained earnings	798,372		751,025
Total LHC Group, Inc. stockholders' equity	1,600,407		1,566,242
Noncontrolling interest — non-redeemable	85,107		85,857
Total stockholders' equity	1,685,514		1,652,099
Total liabilities and stockholders' equity	$    2,914,154		$   2,895,621

 

LHC GROUP, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Amounts in thousands, except per share data) (Unaudited)
	Three months ended    September 30,				Nine months ended   September 30,
	2022		2021		2022		2021
Net service revenue	$       576,913		$       565,451		$    1,724,601		$    1,636,193
Cost of service revenue (excluding depreciation and amortization)	347,772		343,862		1,052,093		972,006
Gross margin	229,141		221,589		672,508		664,187
General and administrative expenses	189,051		176,444		569,800		506,754
Impairment of intangibles and other	2,059		—		4,130		937
Operating income	38,031		45,145		98,578		156,496
Interest expense	(9,053)		(1,135)		(19,631)		(1,541)
Income before income taxes and noncontrolling interest	28,978		44,010		78,947		154,955
Income tax expense	6,966		10,150		17,014		32,909
Net income	22,012		33,860		61,933		122,046
Less net income attributable to noncontrolling interests	4,703		6,126		14,586		22,010
Net income attributable to LHC Group, Inc.'s common stockholders	$         17,309		$         27,734		$         47,347		$       100,036
Earnings per share:
Basic	$              0.57		$              0.89		$              1.55		$              3.21
Diluted	$              0.56		$              0.88		$              1.55		$              3.18
Weighted average shares outstanding:
Basic	30,565		31,238		30,527		31,205
Diluted	30,706		31,434		30,639		31,422

 

LHC GROUP, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited)
	Nine months ended   September 30,
	2022		2021
Operating activities:
Net income	$       61,933		$           122,046
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	17,483		14,899
Amortization of operating lease right of use asset	30,769		27,526
Stock-based compensation expense	15,290		11,717
Deferred income taxes	17,635		23,356
Loss (gain) on disposal of assets	484		(1,190)
Impairment of intangibles and other	4,130		937
Changes in operating assets and liabilities, net of acquisitions:
Receivables	(684)		(27,038)
Prepaid expenses	5,273		397
Other assets	(4,208)		(6,368)
Prepaid income taxes	(11,772)		(11,575)
Prepaid taxes	—		(12,509)
Accounts payable and accrued expenses	16,282		6,626
Salaries, wages, and benefits payable	(11,251)		(9,687)
Contract liabilities - deferred revenue	(101,649)		(141,629)
Operating lease liabilities	(30,568)		(27,472)
Income taxes payable	668		(20,819)
Net amounts due to/from governmental entities	223		(833)
Net cash provided by (used in) operating activities	10,038		(51,616)
Investing activities:
Purchases of property, building and equipment	(14,074)		(23,548)
Proceeds from sale of property, building and equipment	—		3,350
Cash paid for acquisitions, net of cash acquired	(2,570)		(383,475)
Purchase of intangible assets	(100)		—
Proceeds from sale of an entity	—		1,531
Minority interest investments	(15,250)		(10,100)
Net cash used in investing activities	(31,994)		(412,242)
Financing activities:
Proceeds from line of credit	815,155		544,056
Payments on line of credit	(738,352)		(209,056)
Government stimulus advance	—		(93,257)
Proceeds from employee stock purchase plan	1,840		1,877
Payments on deferred financing fees	—		(2,855)
Payments on repurchasing common stock	(34,565)		—
Noncontrolling interest distributions	(16,346)		(22,187)
Withholding taxes paid on stock-based compensation	(4,630)		(11,594)
Purchase of additional controlling interest	(433)		(2,113)
Sale of noncontrolling interest	—		1,934
Net cash provided by financing activities	22,669		206,805
Change in cash	713		(257,053)
Cash at beginning of period	9,809		286,569
Cash at end of period	$       10,522		$             29,516

 

LHC GROUP, INC. AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Amounts in thousands) (Unaudited)
Supplemental disclosures of cash flow information:
Interest paid	$       18,049		$               1,532
Income taxes paid	$       10,701		$             42,036
Non-Cash Operating Activity:
Operating right of use assets in exchange for lease obligations	$       28,435		$             41,776
Reduction to right of use assets and liabilities	$         2,089		$               2,746
Non-Cash Investing Activity:
Net working capital adjustment	$         1,440		$                     —
Accrued capital expenditures	$            126		$               1,807

 

LHC GROUP, INC. AND SUBSIDIARIES SEGMENT INFORMATION (Amounts in thousands) (Unaudited)
	Three months ended September 30, 2022
	Home health services		Hospice services		Home and community- based services		Facility- based services		HCI		Total
Net service revenue	$     373,335		$   103,799		$    47,978		$     31,441		$    20,360		$     576,913
Cost of service revenue (excluding depreciation and amortization)	217,790		68,951		35,727		22,549		2,755		347,772
General and administrative expenses	126,052		32,384		11,893		12,098		6,624		189,051
Impairment of intangibles and other	—		1,590		469		—		—		2,059
Operating income (loss)	29,493		874		(111)		(3,206)		10,981		38,031
Interest expense	(6,347)		(1,356)		(808)		(362)		(180)		(9,053)
Income (loss) before income taxes and noncontrolling interest	23,146		(482)		(919)		(3,568)		10,801		28,978
Income tax expense (benefit)	5,723		(439)		(165)		(927)		2,774		6,966
Net income (loss)	17,423		(43)		(754)		(2,641)		8,027		22,012
Less net income (loss) attributable to non controlling interests	3,838		1,269		(125)		(439)		160		4,703
Net income (loss) attributable to LHC Group, Inc.'s common stockholder	$       13,585		$     (1,312)		$        (629)		$     (2,202)		$      7,867		$       17,309
Total assets	$  1,717,209		$   798,668		$  238,082		$     80,223		$    79,972		$ 2,914,154

 

LHC GROUP, INC. AND SUBSIDIARIES SEGMENT INFORMATION (Amounts in thousands) (Unaudited)
	Three months ended September 30, 2021
	Home health services		Hospice services		Home and community- based services		Facility- based services		HCI		Total
Net service revenue	$     386,699		$     82,653		$     45,800		$     32,415		$     17,884		$    565,451
Cost of service revenue (excluding depreciation and amortization)	230,839		51,631		34,386		23,725		3,281		343,862
General and administrative expenses	126,695		22,548		11,764		11,050		4,387		176,444
Operating income (loss)	29,165		8,474		(350)		(2,360)		10,216		45,145
Interest expense	(811)		(139)		(109)		(54)		(22)		(1,135)
Income (loss) before income taxes and noncontrolling interest	28,354		8,335		(459)		(2,414)		10,194		44,010
Income tax expense (benefit)	6,407		1,874		(99)		(554)		2,522		10,150
Net income (loss)	21,947		6,461		(360)		(1,860)		7,672		33,860
Less net income (loss) attributable to noncontrolling interests	5,157		1,085		77		(187)		(6)		6,126
Net income (loss) attributable to LHC Group, Inc.'s common stockholders	$       16,790		$       5,376		$        (437)		$     (1,673)		$       7,678		$      27,734
Total assets	$  1,632,670		$   681,954		$   239,452		$    83,276		$    75,334		$ 2,712,686

 

LHC GROUP, INC. AND SUBSIDIARIES SEGMENT INFORMATION (Amounts in thousands) (Unaudited)
	Nine months ended September 30, 2022
	Home health services		Hospice services		Home and community- based services		Facility- based services		HCI		Total
Net service revenue	$   1,154,009		$   308,322		$   137,036		$     94,289		$     30,945		$ 1,724,601
Cost of service revenue (excluding depreciation and amortization)	674,508		202,864		96,470		69,584		8,667		1,052,093
General and administrative expenses	387,482		97,152		35,755		35,737		13,674		569,800
Impairment of intangibles and other	930		2,677		523		—		—		4,130
Operating income (loss)	91,089		5,629		4,288		(11,032)		8,604		98,578
Interest expense	(13,805)		(2,803)		(1,785)		(851)		(387)		(19,631)
Income (loss) before income taxes and noncontrolling interest	77,284		2,826		2,503		(11,883)		8,217		78,947
Income tax expense (benefit)	17,057		(3)		680		(2,849)		2,129		17,014
Net income (loss)	60,227		2,829		1,823		(9,034)		6,088		61,933
Less net income (loss) attributable to non controlling interests	12,758		2,837		(74)		(1,085)		150		14,586
Net income (loss) attributable to LHC Group, Inc.'s common stockholder	$        47,469		$             (8)		$       1,897		$     (7,949)		$       5,938		$      47,347

 

LHC GROUP, INC. AND SUBSIDIARIES SEGMENT INFORMATION (Amounts in thousands) (Unaudited)
	Nine months ended September 30, 2021
	Home health services		Hospice services		Home and community- based services		Facility- based services		HCI		Total
Net service revenue	$   1,157,061		$   209,191		$   143,332		$     96,814		$     29,795		$ 1,636,193
Cost of service revenue (excluding depreciation and amortization)	663,137		129,848		103,941		65,360		9,720		972,006
General and administrative expenses	369,337		58,789		35,216		33,213		10,199		506,754
Impairment of intangibles and other	937		—		—		—		—		937
Operating income (loss)	123,650		20,554		4,175		(1,759)		9,876		156,496
Interest expense	(1,099)		(195)		(143)		(73)		(31)		(1,541)
Income (loss) before income taxes and noncontrolling interest	122,551		20,359		4,032		(1,832)		9,845		154,955
Income tax expense (benefit)	26,003		4,221		889		(649)		2,445		32,909
Net income (loss)	96,548		16,138		3,143		(1,183)		7,400		122,046
Less net income (loss) attributable to non controlling interests	17,506		3,308		441		792		(37)		22,010
Net income (loss) attributable to LHC Group, Inc.'s common stockholder	$        79,042		$     12,830		$       2,702		$     (1,975)		$       7,437		$    100,036

 

RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP, INC. (Amounts in thousands) (Unaudited)
		Three Months Ended  September 30,								Nine Months Ended  September 30,
		2022				2021				2022				2021
Net income attributable to LHC Group, Inc.'s common stockholders		$	17,309			$	27,734			$	47,347			$	100,036
Add (net of tax):
Acquisition, de novo and legal expenses (1)		4,244				6,875				14,034				10,352
Closures/relocations/consolidations (2)		3,970				369				9,112				1,548
COVID-19 impact:
PPE, supplies and other expenses (3)		—				10,290				—				27,141
ERP implementation (4)		1,360				498				5,498				1,226
Cost improvement initiatives (5)		3,621				—				13,825				—
Cost report and contract settlements (6)		2,063				—				6,026				—
Hurricane Ida (7)		—				844				—				844
Gain on sale of asset (8)		—				(951)				—				(951)
Adjusted net income attributable to LHC Group, Inc.'s common stockholders		$	32,567			$	45,659			$	95,842			$	140,196

 

RECONCILIATION OF ADJUSTED NET INCOME ATTRIBUTABLE TO LHC GROUP, INC. PER DILUTED SHARE (Unaudited)
		Three Months Ended  September 30,								Nine Months Ended  September 30,
		2022				2021				2022				2021
Net income attributable to LHC Group, Inc.'s common stockholders		$	0.56			$	0.88			$	1.55			$	3.18
Add (net of tax):
Acquisition, de novo and legal expenses (1)		0.14				0.22				0.46				0.33
Closures/relocations/consolidations (2)		0.13				0.01				0.30				0.05
COVID-19 impact:
PPE, supplies and other expenses (3)		—				0.33				—				0.87
ERP implementation (4)		0.04				0.01				0.17				0.03
Cost improvement initiatives (5)		0.12				—				0.45				—
Cost report and contract settlements (6)		0.07				—				0.20				—
Hurricane Ida (7)		—				0.03				—				0.03
Gain on sale of asset (8)		—				(0.03)				—				(0.03)
Adjusted net income attributable to LHC Group, Inc.'s common stockholders		$	1.06			$	1.45			$	3.13			$	4.46

 

RECONCILIATION OF EBITDA AND ADJUSTED EBITDA (Amounts in thousands) (Unaudited)
		Three Months Ended September 30,								Nine Months Ended September 30,
		2022				2021				2022				2021
Net income attributable to LHC Group, Inc.'s common stockholders		$	17,309			$	27,734			$	47,347			$	100,036
Add:
Income tax expense		6,966				10,150				17,014				32,909
Interest expense, net		9,053				1,135				19,631				1,541
Depreciation and amortization		5,759				5,358				17,483				14,899
Adjustment items (*)		21,167				24,415				66,304				54,524
Adjusted EBITDA		$	60,254			$	68,792			$	167,779			$	203,909
* Adjustment items (pre-tax):
Acquisition, de novo and legal expenses (1)		5,888				9,364				19,195				14,072
Closures/relocation/consolidations (2)		5,508				502				12,491				2,098
COVID-19 PPE, supplies and other expenses (3)		—				14,016				—				36,835
ERP implementation (4)		1,886				679				7,505				1,665
Cost improvement initiatives (5)		5,023				—				18,888				—
Cost report and contract settlements (6)		2,862				—				8,225				—
Hurricane Ida (7)		—				1,150				—				1,150
Gain on sale of asset (8)		—				(1,296)				—				(1,296)
Total adjustments		$	21,167			$	24,415			$	66,304			$	54,524

 

1. Expenses and other costs associated with recently announced or completed acquisitions, de novos and the pending acquisition by UnitedHealth Group. ($5.9 million pre-tax in the three months ended September 30, 2022 and $19.2 million pre-tax in the nine months ended September 30, 2022; $9.4 million and $14.1 million pre-tax in the three and nine months ended September 30, 2021, respectively).
2. Loss on the sale of an asset and other expenses associated with a closure or consolidation, including impairment ($5.5 million pre-tax in the three months ended September 30, 2022 and $12.5 million in the nine months ended September 30, 2022; $0.5 million and $2.1 million pre-tax in the three and nine months ended September 30, 2021, respectively).
3. COVID-19 related expenses for purchases of personal protective equipment (PPE), supplies and wage adjustments (No adjustments were made in the three months and nine months ended September 30, 2022; $14.0 million and $36.8 million pre-tax in the three and nine months ended September 30, 2021, respectively).
4. Expenses and other costs associated with the implementation of an Enterprise Resource Planning software ($1.9 million pre-tax in the three months ended September 30, 2022 and $7.5 million pre-tax in the nine months ended September 30, 2022; $0.7 million and $1.7 million pre-tax in the three and nine months ended September 30, 2021, respectively).
5. Expenses associated with cost improvement initiatives implemented in the first three quarters of 2022, which consisted of contract terminations and general and administrative cost reductions ($5.0 million pre-tax in the three months ended September 30, 2022 and $18.9 million pre-tax in the nine months ended September 30, 2022).
6. Expenses associated with a 2004 cost report settlement along with other contract settlements ($1.2 million pre-tax in the three months ended September 30, 2022 and $8.2 million in the nine months ended September 30, 2022).
7. Direct recovery costs associated with Hurricane Ida ($1.2 million pre-tax in the three and nine months ended September 30, 2021).
8. As of December 31, 2020, the Company's assets held for sale was $1.9 million, which consisted of one hospice facility in Knoxville, Tennessee.  The Company sold the property during the third quarter of 2021 for $3.2 million.

 

Contact:	Eric Elliott
	Senior Vice President of Finance
	(337) 233-1307
	eric.elliott@lhcgroup.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/lhc-group-announces-third-quarter-2022-financial-results-301666707.html

SOURCE LHC Group, Inc.

FAQ

What were LHC Group's Q3 2022 earnings results?

LHC Group reported Q3 2022 net service revenue of $576.9 million and net income of $17.3 million.

What is the adjusted earnings per share for LHC Group in Q3 2022?

The adjusted earnings per diluted share for Q3 2022 was $1.06.

Is LHC Group conducting an earnings call for Q3 2022?

No, LHC Group will not conduct a quarterly earnings call due to its pending acquisition by UnitedHealth Group.